Bipolar disorder trials in Poland
8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Where
- Bialystok, Gdansk, Rybnik, Tuszyn, Warsaw
- Age
- 18 years to 65 years
- People
- 424 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07140913 - No phaseTaking peoplePsychophysiological Responses to Six Single-Session Self-Regulation Interventions in a Female Adult With ADHD and Stabilized Bipolar Disorder
- Where
- Poznan
- Age
- 18 years to 35 years
- People
- 1
- Run by
- Poznan University of Physical Education
See details and how to joinNCT07437833 - Phase 3Taking peopleA Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
- Where
- Bialystok, Gdansk, Poznan, Rybnik, Tuszyn, Warsaw
- Age
- 18 years to 65 years
- People
- 450 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06929273 · EU 2024-520259-26-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
- Where
- Bialystok, Gdansk, Poznan, Rybnik, Sosnowiec, Tuszyn, Warsaw
- Age
- 18 years to 65 years
- People
- 274 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06951698 - No phaseTaking peopleMultisite rTMS for Mood, Cognitive Impairment and Other Symptoms of Depression
- Where
- Krakow
- Age
- 18 years to 65 years
- People
- 90
- Run by
- Jakub Antczak
See details and how to joinNCT06363981 - No phaseTaking peopleEffect of Intermittent and Continuous Theta Burst Stimulation on Sleep, Daytime Sleepiness, and Fatigue in Depression
- Where
- Warsaw
- Age
- 18 years to 65 years
- People
- 90
- Run by
- Jakub Antczak
See details and how to joinNCT06371352 - Phase 2Taking peopleStudy to evaluate the efficacy and safety of low-dose aspirin as an add-on to standard therapy in patients with bipolar disorder (ASPIRIN BD)
- Where
- Częstochowa, Swiecie, Warsaw
- Age
- 18 years to 64 years
- People
- 100
- Run by
- Instytut Psychiatrii I Neurologii
See details and how to join2024-516584-86-00 · EU 2024-516584-86-00 - No phaseEnrolling by invitationObservation of Clozapine Treatment Safety in Bipolar Disorder.
- Where
- Gdansk
- Age
- 18 years to 65 years
- People
- 30
- Run by
- Medical University of Gdansk
See details and how to joinNCT06011460